(PharmaNewsWire.Com, January 05, 2018 ) The Global Preventive Vaccine market is estimated at $30.24 Billion in 2015 and is poised to reach $55 billion by 2020 with a compound annual growth rate of 12.74%. The vaccine market accounts for only 5 % of the global pharmaceuticals market. However, recently there has been a substantial growth owing to the rising incidences of cancer & HIV cases. Nevertheless, there has been rapid growth over recent years, with the vaccine market magnifying in value from USD 5 billion in 2000 to almost USD 25 billion in 2013. World Health Organization growth estimations indicate the market may increase in value to almost 60 billion 2020, with the arrival of new therapeutic, preventive and adult vaccines.
The vaccine Market is different from any other product market. Compared to the pharmaceutical market it is relatively small, although growing at a fast rate. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years. The vaccine market is rather concentrated on both supply and demand sides. It is highly regulated and mostly dependent on public purchasers and donor policies. It has very distinct features which increase the complexity of assessing and understanding pricing and procurement in their context.
Increase in funding’s from government for vaccine development, rise in investments by the major market players, rising prevalence of disease, technological advancements to decrease the new vaccine development time, initiatives by NGO’s are some of the factors that are propelling the vaccines market growth. However, massive capital expenditures and stringent regulatory policies, high cost associated with treatment are few factors inhibiting the growth of the market.
• Market Segmentation By Vaccine Type o Live, Attenuated Vaccines o Inactivted Vaccines o Toxoid Vaccines o Subunit vaccines o Conjugate vaccines o DNA vaccines o Recombinant vector vaccines o By End User o Paediatric Vaccine o Pneumococcal o MMR o Varicella o Hepatitis o Poliovirus o HIB o Others o Adult Vaccines o Influenza o Cervical Cancer o Hepatitis o Zoster o Others
Multinational vaccine companies historically have conducted much of the innovation, research, and development in the field of vaccine production. They have used significant revenues, global size, and deeper expertise to fund. Some of the key players influencing the global preventive vaccine market are GlaxoSmithKline, plc., Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
